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Abstract 
Background: The cytotoxic effects on epithelial cells of the human are not observed in 
other strains of Klebsiella  spp and are only observed in K. oxytoca strains. MTT assay was 
used to evaluate cytotoxic activity. In this study, colorimetric method was used to evaluate the 
cytotoxic effect of cytotoxin-producing isolates on Hep-2 cell line and determines the percentage of 
surviving cells. 
Materials and methods: In this study, we collected a total of 75 K. oxytoca strains 
isolate and we  detected the production of toxins and their cytotoxic effects on HEp-2 cells. 
Colorimetric method such as MTT assay  was used to evaluate the cytotoxic effect of 
cytotoxin-producing isolates on Hep-2 cell line and determines the percentage of surviving 
cells. 
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Results: Nine isolates had  cytotoxic effects on HEp-2 cells.  The results of MTT assay 
showed that the isolated strains were different from the control stain in terms of 
toxinogenicity and cytotoxic effects on HEp-2 cells at the studied dilutions (1:3, 1:6, 1:12, 
1:24, 1:48, and 1:96). 
Conclusions: In the current study, Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 
1:12, 1:24, 1:48, and 1:96 supernatant dilutions of cytotoxin-producing  Klebsiella oxytoca 
isolates was different.  
Keywords: cytotoxic effect , cytotoxin, Klebsiella oxytoca, HEp-2 cell, MTT assay 
 
1. Introduction 
  K. oxytoca , as an opportunistic pathogen, produces cytotoxin, which results in peritoneal 
colon destruction. Cytotoxin is one of the pathogenic factors of this bacterium, and one of the 
important factors involved in the virulence of the bacterium [1, 2] ; it is also associated with 
the pathogenicity of K. oxytoca. This bacterium is the etiologic factor of hemorrhagic colitis 
which is associated to the use of antibiotics in adults and the elderly [3]. 
Studies have shown that K. oxytoca can demonstrate its pathogenesis via producing cytotoxin 
in human. K. oxytoca strains associated with the colitis, and mucosal skin infections in 
humans are able to produce cytotoxin, which may be somewhat due to the pathogenesis of 
this bacterium [4]. The feature of this cytotoxin was introduced in 1989 and 1992, when it 
observed that this bacterium could  round and kill the cell lines of HEp-2, HeLa, CHO, and 
Vero in vitro [5, 6]. In addition to K. oxytoca    strains, Micrococcus and Streptomyces strains 
are also able to produce Tilivalline cytotoxin [7]. Tilivalline is the only 
pyrrolobenzodiazepine (PBD) that is produced in the microbiota of human gut and can 
disturb the intestinal epithelial barrier via the induction of apoptosis and reduction of 
epithelial resistance [1]. Cytotoxin is one of the important pathogenic factors, which plays a 
role in the virulence of this bacterium. Cytotoxin is associated with the pathogenesis of K. 
oxytoca [3, 8]. The cytotoxic effects on epithelial cells of the human are not observed in other 
strains of Klebsiella  spp and are only observed in K. oxytoca  strains. This study aimed to 
evaluation the cytotoxic effect of cytotoxin-producing  Klebsiella oxytoca  isolates on the  
HEp-2 cell line by MTT assay. 
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2. Material and Methods 
2.1. Bacterial isolates 
   A total of 75 K. oxytoca    strains were collected from several hospitals( Shariati, Imam  
Khomeini, Imam Hossinn hospitals and noor laboratory) in Tehran between 2015 and 2016. 
Clinical strains were isolated from stool, blood, urine, sputum, and wounds. K. oxytoca    
strains were isolated from 3750 clinical samples, including stool, blood, urine, sputum, and 
wounds. 
2.2. Verification of K. oxytoca    isolates 
  All bacterial strains which underwent standard microbiological tests such as oxidase test; 
glucose and lactose fermentation, gas and H2S production; motility and indole production; 
citrate utilization; urease production; methyl red (MR) and Voges-Proskauer(VP) tests  in 
microbiology laboratories and were detected as K. oxytoca strains were also detected and 
verified by PCR through amplification of Polygalacturonase specific gene (pehX) [9, 10, 11].  
2.3. Cytotoxin production assay 
Production of toxin  determined by cytotoxic effects on HEp-2  cells.  The cytotoxicity assays 
of K. oxytoca  strains were performed using previously described  methods [10, 12]. In brief, 
HEP-2 cell line (ATCC CCL-23) was used for screening this cytotoxin. A 1:1 dilution of the 
filtered supernatant from culture of K. oxytoca    strains with PBS was added to the each well 
of a 96-well plate was seeded with 1x105 HEp-2 cells and inoculated onto HEp-2 cells 
followed by incubation in 5% carbon dioxide at 37 ° C for 72 hours.  A positive cytotoxic 
effect was recorded as cell rounding under light microscopy. The positive control of   
cytotoxin-Producing K. oxytoca MH43-1 was a gift from Dr Christoph Hoegenauer, 
Department of Internal Medicine, Medical University of Graz, Austria. The K. oxytoca    
strain ATCC 13182 served as negative control. 
2.4. MTT assay 
MTT assay (Sigma-Aldrich, USA) was used to evaluate cytotoxic activity. In this study, 
colorimetric method was used to evaluate the cytotoxic effect of cytotoxin-producing isolates 
on Hep-2 cell line and determines the percentage of surviving cells. The MTT assay uses the 
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power of the mitochondrial succinate dehydrogenase enzyme to convert the yellow salt of 
MTT to the purple formazan crystalline which is insoluble in water. After the addition of 
DMSO (Merck, Germany) detergent solvent, it is solved and the produced color is measured 
at the specified wavelength by using an ELISA reader. To do this process, HEp-2 cells are 
passaged in an RPMI 1640 medium (Caisson, USA) containing 10% fetal bovine serum 
(Invitrogen, USA) and 100 u/ml penicillin and 100 µg/ml streptomycin. The trypsin-treated 
cells with a concentration of 1.5 × 104 cells were cultured in each 96-well plate (Biofil, 
China) with a volume of 100 µl. Then, various dilutions of the supernatant (1:3, 1:6, 1:12, 
1:24, 1:48, and 1:96) of the cytotoxin, producing bacteria were added to the wells, and HEp-2 
cells were incubated at 37 ° C with 5% carbon dioxide for 48 hours. Afterward, the cells were 
then examined for cytotoxic effects (cell rounding). In the next step, the wells were washed 
with 200 µl of PBS and then 200 µl of PBS and 25 µl of MTT solution was added to the wells 
and incubated for 1 hour at 37 ° C. Subsequently, optical absorption was recorded by ELISA 
reader (STAT FAX, USA) at a wavelength of 595 nm. The percentage of surviving cells was 
calculated and determined using the following formula. For each dilution, the test was 
repeated three times, and the results were recorded [4, 13]. 
Percentage of surviving cells = Mean optical absorption of cells exposed to the supernatant / 
Mean optical absorption of control cells × 100. 
Based on the results of One-way ANOVA, the test groups were compared to the control 
group. The significance of the data was determined by SPSS software Ver. 22 through using 
one-way ANOVA and Donnett tests at a significance level of P <0.05. 
3. Results 
Of all the isolates, five K. oxytoca  strains isolated from the stool cultures, two strains isolated 
from the blood cultures, one strain isolated from the wound cultures, and one strain isolated 
from the urine cultures had cytotoxic effects on HEp-2 cells. The strains isolated from 
sputum cultures had no cytotoxic effects on HEp-2 cells. 
3.1 MTT results 
Fig. 1 to 9 present the results of the tests determining the percentage of surviving cells 
exposed to different dilutions prepared from the supernatant of the cytotoxin producing 
Klebsiella oxytoca isolates, K. oxytoca MH43-1 strain (cytotoxin producing strain) and K. 
oxytoca 13182 strain (cytotoxin-negative) together with HEp-2 cells. ( Dilution 1: 1:3 
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Supernatant dilution, Dilution 2: 1:6 Supernatant dilution, Dilution 3: 1:12 Supernatant 
dilution, Dilution 4: 1:24 Supernatant dilution, Dilution 5: 1:48 Supernatant dilution, Dilution 
6: 1:96 Supernatant dilution, K. oxytoca MH43-1   , K.o 13182: K. oxytoca   13182) 
 
1:3 supernatant dilution: 
The mean optical absorption of HEp-2 cells exposed to 1:3 supernatant dilution of K.o 1-9 
isolates and K. oxytoca MH43-1 strain and K. oxytoca 13182 strain had a significant 
difference with the mean optical absorption of HEp-2 cells exposed to 1:3 control dilution (P 
<0.05). 
1:6 supernatant dilution: 
The mean optical absorption of HEp-2 cells exposed to 1:6 supernatant dilution of K.o 1-9 
isolates and K. oxytoca MH43-1 strain and K. oxytoca  13182 strain had a significant 
difference with the mean optical absorption of HEp-2 cells exposed to 1:6 control dilution (P 
<0.05). 
1:12 supernatant dilution: 
The mean optical absorption of HEp-2 cells exposed to 1:12 supernatant dilution of K.o 1-9 
isolates and K. oxytoca MH43-1 strain had a significant difference with the mean optical 
absorption of HEp-2 cells exposed to 1:12 control dilution (P <0.05). The mean optical 
absorption of HEp-2 cells exposed to 1:12 supernatant dilution of K. oxytoca 13182 strain did 
not have a significant difference with the mean optical absorption of HEp-2 cells exposed to 
1:12 control dilution (P >0.05). 
1:24 supernatant dilution: 
The mean optical absorption of HEp-2 cells exposed to 1:24 supernatant dilution of K.o 1-9 
isolates and K. oxytoca MH43-1 strain had a significant difference with the mean optical 
absorption of HEp-2 cells exposed to 1:24 control dilution (P <0.05). The mean optical 
absorption of HEp-2 cells exposed to 1:24 supernatant dilution of K. oxytoca  13182 strain 
did not have a significant difference with the mean optical absorption of HEp-2 cells exposed 
to 1:24 control dilution (P >0.05). 
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1:48 supernatant dilution: 
The mean optical absorption of HEp-2 cells exposed to 1:48 supernatant dilution of K.o 1-9 
isolates had a significant difference with the mean optical absorption of HEp-2 cells exposed 
to 1:48 control dilution (P <0.05). The mean optical absorption of HEp-2 cells exposed to 
1:48 supernatant dilution of K. oxytoca  MH43-1 strain and K. oxytoca  13182 strain did not 
have a significant difference with the mean optical absorption of HEp-2 cells exposed to 1:48 
control dilution (P >0.05). 
1:96 supernatant dilution: 
The mean optical absorption of HEp-2 cells exposed to 1:96 supernatant dilution of K.o 1-9 
isolates had a significant difference with the mean optical absorption of HEp-2 cells exposed 
to 1:96 control dilution (P <0.05). The mean optical absorption of HEp-2 cells exposed to 
1:96 supernatant dilution of K. oxytoca MH43-1 strain and K. oxytoca 13182 strain did not 
have a significant difference with the mean optical absorption of HEp-2 cells exposed to 1:96 
control dilution (P >0.05). 
Based on the results shown in Fig. 1 to 9, the highest percentage of surviving cells exposed to 
1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 supernatant dilution, respectively, were related to K.o 2 
(Fig. 2) isolate, K.o 9  isolate (Fig. 9), K.o 9 isolate, K.o 6 isolate (Fig. 6), K.o 2 isolate, and 
K.o 1 isolate (Fig. 1). 
The lowest percentage of surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilution, respectively, were related to K.o 4 isolate (Fig. 4 ), K.o 6 isolate (Fig. 
6), K.o 4 isolate, K.o 8 isolate (Fig. 8), K.o 1,8 isolate, and K.o 7 isolate (Fig. 7). 
Based on the figures presenting the percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 
1:12, 1:24, 1:48, and 1:96 supernatant dilutions of cytotoxin-producing isolates, at 1:3, 1:6, 
1:12, 1:24, 1:48, and 1:96 supernatant dilutions, respectively, K. oxytoca 4 (Fig. 4) , K. 
oxytoca 6 (Fig. 6) , K. oxytoca 4 (Fig. 4) , K. oxytoca 8 (Fig. 8), K. oxytoca 1(Fig. 1) and 8, 
and K. oxytoca 7 (Fig. 7) were the most powerful in producing cytotoxin and had the 
strongest toxigenic effects. 
However, at 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 supernatant dilutions, respectively, K. 
oxytoca  2 (Fig. 2), K. oxytoca 9 (Fig. 9), K. oxytoca  9, K. oxytoca  6 (Fig. 6), K. oxytoca  2 
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(Fig. 2), and K. oxytoca 1 (Fig. 1) were the least powerful in producing cytotoxin and had the 
weakest toxigenic effects. 
The results of MTT assay showed that the isolated strains were different from the control 
stain in terms of toxinogenicity and cytotoxic effects on HEp-2 cells at the studied dilutions 
(the lowest percentage of surviving cells exposed to 1:3 supernatant dilution was related to 
K.o 4 isolate (Fig. 4) and the highest percentage of surviving cells exposed to 1:96 was 
related to K.o1 isolate (Fig. 1). 
4.  Discussion 
K. oxytoca isolated from patients with Septicemia, bacteremia, septic arthritis, soft tissue 
infection, cholecystitis, urinary tract infection and AHHC [1].  In a study by Joaining et al. in 
2009 in Austria, 80 strains of Klebsiella oxytoca isolated from clinical samples were 
investigated in terms of the production of cytotoxin on HEp-2 cell culture. In total, 31 
isolated strains had cytotoxic effects on HEp-2 cell culture. Using MTT assay, the researchers 
investigated the percentage of the survival of HEp-2 cells exposed to 1:3, 1:12, 1:48, 1:192, 
and 1:768 supernatant dilutions of the cytotoxin-producing isolates. The results of MTT assay 
(which was used to investigate the cytotoxic effects) showed that at 1:3 dilution 11 isolates 
had low cytotoxin production capacity, at 1:12 dilution 14 isolates had moderate cytotoxin 
production capacity, and at 1:48 dilution 6 isolates had high cytotoxin production capacity 
[4]. 
In a study by Ulbi et al. in 2012 in Austria, the researcher studied 20 patients with AAHC 
who had been diagnosed between 1996 and 2008. Using the two methods of API20E and 
PCR, 9 isolate of Klebsiella oxytoca were identified. After conducting an assay for cytotoxic 
activity on Hep-2 cell culture, because of the production of cytotoxin, the cytotoxic effects on 
HEp-2 cell culture was reported for 6 isolates of Klebsiella oxytoca. Using the MTT assay, 
the percentage of the survival of HEp-2 cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of cytotoxin producing isolate supernatant was evaluated and the MTT 
assay was positive in more than 50% of the patients. Two isolate at 1:3 and 1:24 dilutions had 
cytotoxin producing capacity and toxicogenic effects. One of the Klebsiella oxytoca isolates 
at 1:48 dilution, like 1:6 dilution, had cytotoxin producing capacity and high toxicogenic 
effects. The figures presenting the percentage of the survival of HEp-2 cells exposed to 
dilution 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 supernatant dilutions for the six cytotoxin 
producing isolate showed the lowest percentage of surviving cells exposed to 1:3 supernatant 
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dilution was related to the two isolated Klebsiella oxytoca strains and the highest percentage 
of surviving cells exposed to 1:96 supernatant dilution was related to a Klebsiella oxytoca 
strain isolated from the stool of a patient with AAHC [15]. The results of MTT assay reported 
by the mentioned study are consistent with our results; however, in Ulbi et al.’s study the 
Klebsiella oxytoca strains were isolated from the stool of patients with AAHC, while in our 
study, the Klebsiella oxytoca strains were isolated from clinical samples of the patients (stool, 
urine, blood, wounds, and sputum). In our  study, isolated strains were different in terms of 
toxinogenicity and cytotoxic effects on HEp-2 cells at the 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions. 
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Fig. 1. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca 1, K. oxytoca MH43-1   strain, and K. oxytoca 
13182 strain 
 
Fig. 2. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca  2, K. oxytoca MH43-1  strain, and K. oxytoca  
13182 strain 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Fig. 3. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca 3, K. oxytoca MH43-1  strain, and K. oxytoca  
13182 strain 
 
Fig. 4. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca  4, K. oxytoca MH43-1 strain, and K. oxytoca 
13182 strain 
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Fig. 5. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of K. oxytoca  5, K. oxytoca MH43-1  strain, and K. oxytoca  
13182 strain 
 
Fig. 6. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca 6, K. oxytoca  MH43-1 strain, and K. oxytoca 
13182 strain 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Fig. 7. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca 7, K. oxytoca  MH43-1 strain, and K. oxytoca  
13182 strain 
 
Fig. 8. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca  8, K. oxytoca MH43-1  strain, and K. oxytoca 
13182 strain 
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Fig. 9. Percentage of Hep-2 surviving cells exposed to 1:3, 1:6, 1:12, 1:24, 1:48, and 1:96 
supernatant dilutions of isolates of  K. oxytoca  9, K. oxytoca  MH43-1  strain, and K. oxytoca 
13182 strain 
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Nine K. oxytoca isolates had  cytotoxic effects on HEp-2 cells. 
MTT assay  was used to evaluate the cytotoxic effect of cytotoxin on Hep-2 cells. 
MTT assay  was used to determines the percentage of surviving cells. 
Isolated strains were different in terms of toxinogenicity and cytotoxic effects on HEp-2 cells. 
Percentage of Hep-2 surviving cells exposed to supernatant dilutions of cytotoxin was different.  
 
 
 
